MedTrace Logo

Serum Endocan Levels and Gestational Diabetes

NCT05237895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2022-08-05

No results posted yet for this study

Summary

In diabetic patients, serum endocan level has been significantly increased in patients and the levels on the long-term complications are correlated. Based on the Iinformation obtained from these studies, it can be said that there is a strong association between diabetes and serum endocan levels.

Conditions

  • Gestational Diabetes
  • Endocan

Interventions

DIAGNOSTIC_TEST

Serum Endocan Levels

Detection of Serum Endocan Levels and detection of possible diagnostic association with gestational diabetes

Sponsors & Collaborators

  • Gaziosmanpasa Research and Education Hospital

    lead OTHER_GOV

Principal Investigators

  • elif yıldız, MD · Gaziosmanpasa Research and Education Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-03
Primary Completion
2022-05-05
Completion
2022-05-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05237895 on ClinicalTrials.gov